AI-powered website aims to ease life after breast cancer

NCT ID NCT05322460

Recruiting now Symptom relief Sponsor: Cristina García-Vivar Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing a web-based program called CUMACA-M that uses artificial intelligence to help long-term breast cancer survivors (at least 5 years past treatment) manage ongoing physical, emotional, and social issues. The program offers personalized modules to address each woman's specific needs. Researchers will measure changes in quality of life and self-efficacy in 182 participants.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: CUMACA-M Program (web-based tailored intervention using artificial intelligence)
What this could lead to: If it works, this could provide a practical, scalable way to help long-term breast cancer survivors manage lingering physical, emotional, and social challenges.
What could go wrong: This is a relatively small trial testing a behavioral intervention, not a drug. The effect may be modest, and results may not apply to all survivors.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LONG-TERM EFFECTS OF CANCER TREATMENT LONG-TERM EFFECTS SECONDARY TO CANCER THERAPY IN ADULTS

AI-powered website aims to ease life after breast cancer

Summary

What this could mean

Get notified about this study

Conditions

As listed by the trial registrant

Contacts and locations

Locations

More trials for these conditions